Expert Witness

The developers of generic versions of successful medicinal products will almost certainly be sued. This is a delaying tactic that is available to the innovator under the Hatch-Waxman legislation. There are two things that can be done to make the outcome more certain for the generic company:

Good advice at the start of, and during the development project can save money long term.

Enlisting the services of properly qualified expert witnesses as early as possible when litigation is inevitable.

FinnBrit Consulting provides experienced expert witness assistance for all drug formulation and excipient related legal issues.

Find us on FaceBook


All information published throughout is intended for information only, and does not contain any warranties, implied or otherwise.

Copyright © 2007 FinnBrit Consulting and Lenk Design. All rights reserved.

Site Map